On another note, we gather that Mah Sing’s registration with US Food and Drug Administration (FDA) has been approved recently and certificate will be issued within the next few days. Meanwhile, Mah Sing is also in the midst of getting CE Marking Certification for gloves export to European countries.
Aiyoh, this President haih. Nobody is attacking you la. You think everyone here not afraid of losing money meh? We are here because we have confident with MahSing. Just make sure to reserve some fund for averaging down price, in case. Btw, Trump is not the president anymore, and so is mike.
(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 15 October 2020 in relation to the Proposed Diversification)
Further to our announcements on 15 October 2020 and 16 October 2020, Mah Sing wishes to provide additional information in connection to the Proposed Diversification. MSHSB's application for the US Food and Drug Administration (FDA) registration has been approved and is currently pending the issuance of certificate by Registrar Corp that MSHSB is registered with the FDA.
(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 15 October 2020 in relation to the Proposed Diversification)
Further to our announcements on 15 October 2020 and 16 October 2020, Mah Sing wishes to provide additional information in connection to the Proposed Diversification. MSHSB's application for the US Food and Drug Administration (FDA) registration has been approved and is currently pending the issuance of certificate by Registrar Corp that MSHSB is registered with the FDA.
I personally feel that every investors should invest in Mahsing. The management team lead by Tan Sri is too efficient. The days ahead is very bright for MahSing.
Well, you can choose to be in denial mode but that is my personal opinion. I have invested in MahSing before this glove thing and still holding those shares. If you want to derive profits solely from glove, then there are 4 top glove counters to invest in which I did also. I am just a small time investor, I play goreng stocks as well but at the end of the day, I top up my stocks in selected counters and Mah Sing is one of them.
Great New!! salute Mahsing... everything settle only announce... as i said early mahsing pattern is complete everything only make official announcement.. compare to other company is they are announcement first and then doing it...
Mah Sing {Tan Sri Leong } has the funds plus a well formulated plan in their diversification into health care { PPE & gloves } under Mah Sing Healthcare. Credit must be given to Tan Sri Leong everything done within the armpit. Their foray into gloves, ppe and vaccine needs foresight
Phase one production target : 3.68B pieces of gloves.
At a conservative profit of USD15 per 1000 (pre covid ASPs), it works out to be about 9 sen per share, at a conservative 15 times PE...it's RM1.35 (gloves alone).....fair price plus property should be above RM2.00.
Phase two production target (2022) ; another 3.68B pieces.
Mahsing is now a value (property) + growth (gloves) stock.
But the trading is still volatile.....if want to buy is for keep....
KUALA LUMPUR: The benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) is likely to revisit the 1,800 mark — a level last seen in 2018 — by end-2021, if a snap election is called next year.
Halo, producing gloves is a sure thing. What counting chicken before they are hatched? Already secure US FDA approval lah. @strattegist, you must be cyber trooper from KYY, the arrogant cunning old folk!
Mah Sing’s next venture: Glove production ------------------------------------------- Saturday, 21 Nov 2020
“FORTY-ONE years ago, we started our plastics business and today we are one of the biggest high-tech plastic product manufacturer and one of the largest plastic pallets producer in Malaysia, ” said Mah Sing founder and group managing director Tan Sri Datuk Seri Leong Hoy Kum.
“We started our first property project 26 years ago and now we are a well-established property player with 50 projects.
“In 2020, we started our new venture into gloves and we target to be one of the top five producers in Malaysia in the future. Now, Mah Sing has its presence in property, plastics and glove manufacturing businesses.”
• Incepted in 1979: 41 years of manufacturing experience.
• Four factories: Two in Malaysia, two in Indonesia.
• Largest clamping force machines in South-East Asia: 75 injection moulding machines with up to 4,000 tonnes clamping force.
• RM16.5mil invested in automation of production lines in Malaysia.
• Export market to 45 countries: 40% of Malaysian sales and revenue derived from export.
• MNC clientele in key industries including food & beverages, electronic & electrical, automotive, healthcare, petrochemical industries, plantation & oleochemicals and pharmaceutical.
• Remaining landbank of 811ha with remaining gross development value and unbilled sales totalling approximately RM24.64bil (as at June 30,2020).
• Continue to focus on providing affordably-priced homes of good quality with 91% of the group’s target sales in 2020 from residential properties priced below RM700,000.
Mah Sing enters new period of growth in proposed glove manufacturing and other medical device products
• First gloves manufacturing factory in Kapar, Klang – 12 new production lines with maximum production capacity up to 3.68 billion pieces of gloves per annum in Phase 1.
• Plan to start proposed glove production in April 2021 with ready factory for installation of glove dipping machinery.
• Targets expansion of 12 additional new production lines in Phase 2 to increase capacity up to another 3.68 billion pieces of gloves per annum if demand exceeds supply.
• Aims to be the top five producers in Malaysia, targets gradual expansion up to 100 lines, potentially producing up to 30 billion pieces if demand permits.
At this juncture, Mah Sing Healthcare has secured letters of intent from several prospective customers and the cumulative indicative orders have already exceeded the estimated maximum capacity for both phases of the Kapar factory.
If demand permits, Mah Sing Healthcare will gradually expand up to 100 production lines as part of future expansion plans. These 100 production lines could potentially produce approximately 30 plus billion pieces of gloves per annum.
As the Kapar factory is expected to start its operation with six production lines as early as 2Q 2021, the group is in a good position to take advantage of the high spot price of gloves.
Mah Sing expects the proposed glove manufacturing business to generate sales for the group relatively quickly with the projected contribution estimated to come in as early as 2Q 2021.
The new proposed gloves business, which predominantly targets the export market, will allow Mah Sing to ride on the booming glove-manufacturing segment and further strengthen its manufacturing division, which is currently focusing on plastics business.
This is expected to provide the group access to the global market and generate more recurring and steady income for the group. This will be a good complement to the property business which focused on the domestic market, and more cyclical in nature.
The group is also pleased to note the recent positive news flow regarding a potential vaccine for the pandemic.
Notwithstanding a viable vaccine for mass use being available, Mah Sing believes the demand for gloves is expected to persist post-pandemic, underpinned by stricter regulations and the increase in awareness of the importance of hygienic practices, especially in emerging markets where the glove consumption per capita is still low as compared with developed countries, which signals more room for long-te
No matters how good your company producing but the share prices was below market price. As previously target price set by bank was RM1.40. The company fundamental basis of share prices must be strong & solid as foreign company will survey the share prices first then check the company making money or not.
Will the market crash if budget 2021 cannot be passed this coming Thursday (26/10/2020)? These are the 4 possible scenarios:
1. Parliament will be dissolved and a snap election will be called 2. A state of Emergency in the whole country will be declared by YDPA 3. Muhyiddin will resign and YDPA will appoint an interim PM 4. YDPA will appoint a new PM who has majority MPs support. A new budget 2021 also will be tabled by the new appointed PM.
Will the market go down? Will it crash? Take profit now or wait?
KUALA LUMPUR: The benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) is likely to revisit the 1,800 mark — a level last seen in 2018 — by end-2021, if a snap election is called next year.
“Many of them expect once the pandemic is stabilised and the CMCO removed, the snap election can happen as soon as January 2021,” he said.
DDNK believes that the snap election would be able to resolve the current domestic political situation and hence attract more foreign inflows into the local market and push it higher next year.
“This (snap election) will be one of the biggest catalysts for the market’s bullishness next year,” he told Bernama.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,533 posts
Posted by pang72 > 2020-11-20 14:33 | Report Abuse
On another note, we gather that Mah Sing’s registration with US Food and Drug Administration (FDA) has been approved recently and certificate will be issued within the next few days. Meanwhile, Mah Sing is also in the midst of getting CE Marking Certification for gloves export to European countries.
NO WONDER BIG GORENG LAH!!!
FDA GRANTED APPROVAL!!